Literature DB >> 12187083

Hospitalizations for valvular heart disease in chronic dialysis patients in the United States.

Kevin C Abbott1, Lawrence Y Agodoa.   

Abstract

BACKGROUND: Valvular heart disease has not been studied in a national population of end stage renal disease patients.
METHODS: 327,993 dialysis patients in the United States Renal Data System initiated from 1 January 1992 to 30 June 1997 were analyzed in a historical cohort study of patients hospitalized for valvular heart disease (ICD9 Code 424.x, excluding endocarditis, and 394.x-397.x).
RESULTS: 2,778 dialysis patients were hospitalized for VHD (incidence rate, 3.57 per 1,000 person years), and dialysis patients had an age-adjusted incidence ratio for valvular heart disease of 5.06 (95% confidence interval, 4.00-6.42) compared to the general population in 1996. In Cox regression analysis, time to hospitalization for valvular heart disease was associated with earlier year of first dialysis, increased age, congestive heart failure and use of erythropoietin prior to dialysis, while African-American race (AHR 0.62, 0.52-0.74) was associated with decreased risk of hospitalization for valvular heart disease. Patients hospitalized for valvular heart disease had increased mortality compared to all other dialysis patients (adjusted hazard ratio by Cox regression 1.35, 95% CI, 1.25-1.46).
CONCLUSIONS: Dialysis patients were at increased risk for hospitalizations for valvular heart disease compared to the general population, which substantially decreased patient survival. The reasons for the decreased risk of African-Americans on chronic dialysis for this complication should be the subject of future trials. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12187083     DOI: 10.1159/000064476

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

Review 1.  [Anticoagulation in patients with chronic kidney disease : Recommendations from the working group "Heart-Kidney" of the German Cardiac Society and the German Society of Nephrology].

Authors:  G Schlieper; V Schwenger; A Remppis; T Keller; R Dechend; S Massberg; S Baldus; T Weinreich; G Hetzel; J Floege; F Mahfoud; D Fliser
Journal:  Internist (Berl)       Date:  2017-05       Impact factor: 0.743

2.  Survival of kidney transplantation patients in the United States after cardiac valve replacement.

Authors:  Alok Sharma; David T Gilbertson; Charles A Herzog
Journal:  Circulation       Date:  2010-06-14       Impact factor: 29.690

3.  Infective Endocarditis in Patients with Kidney Failure: Chronic Dialysis and Kidney Transplant.

Authors:  James H.E. Ireland; James T. McCarthy
Journal:  Curr Infect Dis Rep       Date:  2003-08       Impact factor: 3.725

4.  Race/ethnicity, age, and risk of hospital admission and length of stay during the first year of maintenance hemodialysis.

Authors:  Guofen Yan; Keith C Norris; Tom Greene; Alison J Yu; Jennie Z Ma; Wei Yu; Alfred K Cheung
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-19       Impact factor: 8.237

5.  Outcomes of Surgical Mitral and Aortic Valve Replacements Among Kidney Transplant Candidates: Implications for Valve Selection.

Authors:  David K Ngendahimana; Salil V Deo; Varun Sundaram; Krista L Lentine; Charles A Herzog; Laith Al Dahabreh; Titte R Srinivas; Kenneth D Chavin; Nagaraju Sarabu
Journal:  J Am Heart Assoc       Date:  2021-02-18       Impact factor: 5.501

6.  Comparative effectiveness studies to improve clinical outcomes in end stage renal disease: the DEcIDE patient outcomes in end stage renal disease study.

Authors:  L Ebony Boulware; Navdeep Tangri; Patti L Ephraim; Julia J Scialla; Stephen M Sozio; Deidra C Crews; Tariq Shafi; Dana C Miskulin; Jiannong Liu; Wendy St Peter; Bernard G Jaar; Albert W Wu; Neil R Powe; Sankar D Navaneethan; Karen Bandeen-Roche
Journal:  BMC Nephrol       Date:  2012-12-06       Impact factor: 2.388

7.  Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality.

Authors:  Kevin C Abbott; Fernando C Trespalacios; Allen J Taylor; Lawrence Y Agodoa
Journal:  BMC Nephrol       Date:  2003-01-24       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.